Täby, Sweden

Toomas Moks

This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignee: Annexin Pharmaceuticals Ab. Active years: 2022-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toomas Moks. Retrieved from https://idiyas.com/inventor/toomas-moks

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2022-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Toomas Moks: Innovator in Protein Recovery Processes

Introduction

Toomas Moks is a notable inventor based in Taby, Sweden. He has made significant contributions to the field of biochemistry, particularly in the recovery and purification of intracellular proteins. With a total of 2 patents, Moks has demonstrated his expertise and innovative spirit in the scientific community.

Latest Patents

Moks' latest patents focus on the process of manufacturing annexin V. The invention provides a method for recovering and purifying a recombinantly expressed intracellular protein, specifically Annexin A5 (AnxA5), from endotoxin-producing host cells. The process involves releasing the intracellular protein from the host cell using a homogenization buffer that contains non-ionic detergent. Notably, the method does not require any centrifugation steps for the recovery and purification of the AnxA5 protein after its release, ensuring that the protein remains in solution throughout the process, except when temporarily bound to chromatographic resins.

Career Highlights

Toomas Moks is associated with Annexin Pharmaceuticals AB, where he applies his knowledge and skills to advance the field of protein recovery. His work has been instrumental in developing efficient methods for protein purification, which are crucial for various applications in biotechnology and pharmaceuticals.

Collaborations

Moks collaborates with Jan Christoph Reich, contributing to the innovative projects at Annexin Pharmaceuticals AB. Their combined expertise enhances the research and development efforts within the company.

Conclusion

Toomas Moks is a distinguished inventor whose work in protein recovery processes has the potential to impact the biotechnology industry significantly. His innovative approaches and collaborations continue to drive advancements in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…